The use of volume-modulated arc therapy to deliver intensity-modulated radiation therapy to prostate cancer patients results in an overall reduction in treatment time of approximately 14 percent, a new study suggests.
The use of volume-modulated arc therapy to deliver intensity-modulated radiation therapy to prostate cancer patients results in an overall reduction in treatment time of approximately 14 percent, a new study suggests.